首页|从质量控制角度探讨中药新药临床试验设计中的问题与解决措施

从质量控制角度探讨中药新药临床试验设计中的问题与解决措施

扫码查看
一个科学、规范、具有可行性的试验设计是获得可靠数据与保障临床试验质量的基础.本文通过收集和整理一家药物临床试验机构承接的注册类中药品种临床试验资料,归纳分析试验设计中存在的问题,将纳入分析的18 项中药临床试验审查中发现的问题汇总分类为不符合法规要求、方案内容描述不清晰、试验方案和病例报告表等试验文件设计的可行性差、试验操作要求在不同研究文件或同一文件前后不一致、行文错误、其他等6 类.针对以上问题,探讨申办者、研究者、临床试验机构三方为保障设计质量可以采取的措施,以期为提高临床试验质量提供参考.
Discussion on the issues and solutions in clinical trial design of new traditional Chinese medicines from the perspective of quality control
A scientific,standardized,and feasible trial design is the basis for obtaining reliable data and guaranteeing the quality of clinical trials.In this study,the authors gathered and organized the information of clinical trials of registered traditional Chinese medicines varieties undertaken by a drug clinical trial institution,summarized and analyzed the issues in the clinical trial design.The issues found in the review of 18 clinical trials of traditional Chinese medicine were summarized and classified into six categories:non-compliance with regulatory requirements,unclear description of protocol content,poor feasibility of design of clinical trial documents such as trial protocol and case report form,inconsistent operation requirements before and after different research documents or the same document,writing errors,and others.In view of the above problems,the authors put forward the countermeasures that can be taken by the sponsor,investigator,and clinical trial institution to ensure the quality of the design,in order to provide reference for improving the quality of clinical trials.

clinical trialnew traditional Chinese medicinequality controlexperimental design

谭琴、李庆娜、肖梦丽、应佳珂、赵梦杰、冀瑾瑾、陆芳、邱攀博

展开 >

中国中医科学院西苑医院临床药理研究所,国家药品监督管理局中药临床研究与评价重点实验室,国家中医心血管病临床医学研究中心,北京 100091

临床试验 中药新药 质量控制 试验设计

中国中医科学院科技创新工程项目

CI2021A04704

2024

中国新药杂志
中国医药科技出版社 中国医药集团总公司 中国药学会

中国新药杂志

CSTPCD北大核心
影响因子:1.039
ISSN:1003-3734
年,卷(期):2024.33(8)
  • 10